Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1081–1104 of 3,713 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Muscle Disorders Clear all

Conditions: Sarcopenia, Diabetes Mellitus, Aging
Interventions: Resistance exercise training, Bed rest, Intensive physical therapy; Behavioral
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 60 Years to 85 Years
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Multiple Sclerosis Spasticity
Interventions: BMS-986368, Placebo; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 17
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Aurora, Colorado + 13 more

Conditions: Bladder Cancer
Interventions: Tamoxifen Citrate; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 21 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Fibromyalgia
Interventions: placebo, Xyrem®; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 573 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 71
States / cities: Auburn, Alabama • Birmingham, Alabama • Montgomery, Alabama + 61 more

Conditions: Spinal Muscular Atrophy
Interventions: nusinersen, Sham procedure; Drug · Procedure
Lead sponsor: Biogen; Industry
Eligibility: Up to 210 Days
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 12
States / cities: Los Angeles, California • Aurora, Colorado • Orlando, Florida + 9 more

Conditions: Fibromyalgia, Insomnia
Interventions: Behavioral insomnia therapy; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Spinal Muscular Atrophy
Interventions: AVXS-101; Genetic
Lead sponsor: United BioSource, LLC; Industry
Eligibility: Not listed
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Fibromyalgia
Interventions: RINCE; Device
Lead sponsor: Cerephex Corporation; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Pontiac, Michigan

Conditions: Iron Deficiency, Fibromyalgia
Interventions: Injectafer, Placebo; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Franklin, Tennessee

Conditions: Trauma, Critical Illness
Interventions: Nutrition Supplements - Fresubin KCAL Drinks; Dietary Supplement
Lead sponsor: Duke University; Other
Eligibility: 45 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Local Anesthetic Complication, Local Anesthetic Drug Adverse Reaction
Interventions: Not listed
Lead sponsor: Benaroya Research Institute; Other
Eligibility: Not listed
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Cerebral Palsy
Interventions: SPIO® Core-MAX® Expedition thoracolumbosacral orthosis, Standard Care Therapy option; Device · Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 6 Months to 18 Months
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Pompe Disease (Late-Onset), Glycogen Storage Disease Type II (GSD II), Glycogenesis 2 Acid Maltase Deficiency
Interventions: Alglucosidase Alfa; Biological
Lead sponsor: Genzyme, a Sanofi Company; Industry
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 9
States / cities: Orange, California • Gainesville, Florida • Kansas City, Kansas + 6 more

Conditions: Chronic Fatigue Syndrome, Fibromyalgia, Gulf War Illness, Multiple Chemical Sensitivity, Interstitial Cystitis, Irritable Bowel Syndrome
Interventions: Not listed
Lead sponsor: Georgetown University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Amputation, Phantom Limb Pain, Hoffman's Reflex
Interventions: Transcutaneous spinal cord stimulation; Device
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 70 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania

Conditions: Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma, Ewing Sarcoma, Wilms Tumor, Desmoplastic Small Round Cell Tumor
Interventions: Enoblituzumab; Drug
Lead sponsor: MacroGenics; Industry
Eligibility: 1 Year to 35 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 6
States / cities: Palo Alto, California • Bethesda, Maryland • Philadelphia, Pennsylvania + 3 more

Conditions: Fatigue, Stress, Burnout, Professional, Musculoskeletal Pain, Back Pain, Neck Pain, Headache, Dizziness, Sleep Disturbance, Chest Pain, Syncope, Cardiovascular Diseases, Shortness of Breath, Gastrointestinal Diseases
Interventions: Not listed
Lead sponsor: TMRW Life Sciences; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 246 participants
Timeline: 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor, Rhabdomyosarcoma, Neuroblastoma, Medulloblastoma, Diffuse Intrinsic Pontine Glioma
Interventions: Palbociclib, Temozolomide, Irinotecan, Topotecan, Cyclophosphamide; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 2 Years to 20 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 56
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 37 more

Conditions: TMJ Disorder, Myofacial Pain, TMD
Interventions: CBD Oil, Hemp Oil; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Muscle Spasm
Interventions: Active ultrasound therapy device, Placebo ultrasound therapy device; Device
Lead sponsor: ZetrOZ, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Trumbull, Connecticut

Conditions: Fibromyalgia, Insomnia
Interventions: Eszopiclone, placebo; Drug
Lead sponsor: Lesley A. Allen, Ph.D.; Other
Eligibility: 18 Years to 64 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Spinal Cord Injury
Interventions: Exoskeleton Training, Muscle Biopsies, MRI; Device · Other
Lead sponsor: Kessler Foundation; Other
Eligibility: 21 Years to 45 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Pelvic Floor Injury, Urinary Incontinence, Stool Incontinence
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Rotator Cuff Tendonitis, Bicipital Tendonitis, Subdeltoid Bursitis of the Shoulder, Subacromial Bursitis of the Shoulder, Medial Epicondylitis of the Elbow, Lateral Epicondylitis of the Elbow, DeQuervain's Tenosynovitis of the Wrist
Interventions: diclofenac sodium, Matching Placebo; Drug
Lead sponsor: Cerimon Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 308 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Austin, Texas

Search by objective public record fields.

Identifying Therapeutic Targets of Accelerated Sarcopenia

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy

Behavioral Insomnia Therapy for Fibromyalgia

AveXis Managed Access Program Cohort for Access to AVXS-101

Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - St. Joseph Mercy Oakland

Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia

Optimizing Recovery in Trauma Patients by Integrating Enhanced Nutrition Delivery

Defining Normal Postoperative Magnetic Resonance Imaging After Total Knee Arthroplasty

Orthosis to Improve Trunk Control in Infants Age 6-18 Months

Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa

Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome

Neuromodulation in Lower Limb Amputees

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

The U.S. Embryologist Fatigue Study

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region

Low Intensity Ultrasound Therapy for Upper Back Pain Relief

Eszopiclone in the Treatment of Insomnia and Fibromyalgia

Non-Ambulatory SCI Walk Using a Robotic Exoskeleton: Effect on Bone and Muscle

3D Ultrasound in Women With Vacuum or Forceps Deliveries

Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis